Under construction – not a live service
Sign in
Not yet recruitingNo phase

Effectiveness of Neuromuscular Electrical Stimulation Added to Oral Motor Therapy in Cerebral Palsy

Key facts

Who runs it
Aslinur Keles Ercisli, MD, PhD
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
30 people, planned
Started
1 May 2026
Planned end
1 Aug 2026
Type of study
Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Oral Motor Therapy
  • Neuromuscular Electrical Stimulation (NMES)
  • Sham Neuromuscular Electrical Stimulation (Sham NMES)
Record updated
15 April 2026

Who can take part

Age
4 years to 17 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Diagnosis of cerebral palsy (unilateral/bilateral spastic, ataxic, dyskinetic, or mixed type)
  • Presence of drooling control problems
  • Age between 4 and 17 years
  • Gross Motor Function Classification System (GMFCS) levels 2, 3, 4, or 5
  • Stable drooling severity for at least one month prior to enrollment
  • Drooling Severity and Frequency Scale (DSFS) score of 3 or higher

Who cannot take part

  • Use of medications affecting drooling within the past 72 hours
  • Upper respiratory tract infection and/or salivary gland infection during the study period
  • History of botulinum toxin injection to the salivary glands
  • Diagnosis of dysphagia

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 4 and 17 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized, controlled, single-blind trial aims to investigate the effectiveness of neuromuscular electrical stimulation (NMES) combined with oral motor therapy in reducing drooling severity among children with cerebral palsy. Participants will be allocated to an intervention group (oral motor therapy plus NMES), a control group (oral motor therapy alone) and a sham group (oral motor therapy with placebo NMES).

The 3 groups in the trial

  • Oral Motor Therapy Plus NMESTreatment being tested

    Participants assigned to this arm will receive oral motor therapy combined with active neuromuscular electrical stimulation (NMES) applied to the masseter and orbicularis oris muscles.

    Treatment: Oral Motor Therapy and Neuromuscular Electrical Stimulation (NMES)

  • Oral Motor TherapyOther group

    Participants assigned to this arm will receive oral motor therapy without any NMES. This is a behavioral therapy.

  • Oral Motor Therapy Plus Sham NMESSham treatment, for comparison

    Participants assigned to this arm will receive oral motor therapy combined with sham NMES that does not deliver active stimulation.

    Treatment: Oral Motor Therapy and Sham Neuromuscular Electrical Stimulation (Sham NMES)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effectiveness of Neuromuscular Electrical Stimulation Added to Oral Motor Therapy in Children With Cerebral Palsy Experiencing Drooling Problems: A Randomized Controlled Trial
Fit questions
Built from NCT07069257, who can take part
Record updated
15 April 2026